LBA82 Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study
| Autor: | Crawford, J., Groarke, J.D., Collins, S.M., Lubaczewski, S., Roeland, E.J., Naito, T., Hendifar, A.E., Fallon, M.T., Takayama, K., Asmis, T.R., Dunne, R.F., Rossulek, M., Qiu, R., Saxena, A.R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1269-S1269 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|